Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. TTY Biopharm Company Limited Lioudu Factory
EIR
•TTY Biopharm Company Limited Lioudu Factory•August 30, 2022

TTY Biopharm Company Limited Lioudu Factory – FDA EIR, Aug 30, 2022

Record Details

The FDA conducted a pre-approval inspection of TTY Biopharm Company Limited Lioudu Factory from August 22 to August 30, 2022. This inspection, carried out under the regulatory framework of Compliance Program 7346.832 for Pre-Approval Inspections, focused on the facility's readiness for commercial manufacturing, conformance to application, and data integrity for Amphotericin B Liposomes for Injection, ANDA 214010.

Upon completion, a four-item FDA 483 (Inspectional Observations) was issued. Key deficiencies noted included the failure to maintain reserve samples for submitted batches, inadequate management of environmental monitoring contact plates for an injectable production line, insufficient training of personnel on Current Good Manufacturing Practice (21 CFR 211) regulations, and the absence of hot water in specific hand washing areas and toilet facilities.

The firm's Senior Director of Production & Operation committed to providing a written response to the FDA 483 observations. The inspection was classified as Voluntary Action Indicated (VAI), signifying that the company is expected to implement corrective actions for the identified issues. Notably, an approval recommendation has been made for the Amphotericin B Liposomes for Injection, ANDA 214010, despite these observations.

Company
TTY Biopharm Company Limited Lioudu Factory
Inspection date
August 30, 2022
Product type
drugs
Office
Office of Regulatory Affairs
People
  • Kham Phommachanh (Investigator)
  • Rita Vick (other)
View Company Profile

ID · 1d56e720-8343-41b6-b508-be652011c2b2

Violation Codes2
21 CFR 21121 CFR 820.50

Full citation text and observation details available on the Dashboard.

Other documents for TTY Biopharm Company Limited Lioudu Factory
  • 483 - 2022-08-30August 30, 2022

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore TTY Biopharm Company Limited Lioudu Factory
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.